GlobeImmune Inc.

GlobeImmune Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$2 M
Shares Outstanding
5.75 M
Public Float
-

Profile

Address
1450 Infinite Drive
Louisville Colorado 80027
United States
Employees -
Website http://www.globeimmune.com
Updated 07/08/2019
GlobeImmune, Inc. is a biopharmaceutical company. It engages in developing therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C.

Financials

View All

Timothy C. Rodell
President, Chief Executive Officer & Director
Jerel A. Banks
Director